Sexual Well-being of Women Undergoing Mastectomy and Reconstruction
NCT ID: NCT07234461
Last Updated: 2026-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2026-01-21
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This data can support preoperative patient counselling and the prevention and care of adverse effects of cancer treatments.
Specific subpopulations of mastectomy women showing severe sexual impairment can be outlined; they may benefit from lifestyle changes and intervention strategies (intravaginal use of diazepam, local hyaluronic acid, intravaginal use of spermidine, pelvic floor gymnastic and physiotherapy).
Our goal is to improve quality of life of breast cancer patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain and Functional Recovery After Mastectomy and IBR by Implant: Prepectoral Versus Subpectoral Technique
NCT05527769
Opting for Breast Reconstruction After Mastectomy or Not: Search for Influencing Factors
NCT03039348
Socio-aesthetic Intervention on Body Image and Quality of Life in Women With Breast Cancer.
NCT00210145
Cosmetic Outcome, Patient-reported Outcomes, and Reconstruction-related Complications in Breast Cancer Women Treated With or Without Post-mastectomy Radiation Therapy
NCT03523078
Quality of Life After Conservative Oncoplastic Surgery in Breast Cancer Patients (IRONY: lIfe afteR ONcoplastic surgerY)
NCT05842148
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Survey
At 1-year follow-up, breast cancer patients who underwent mastectomy and reconstruction are asked to complete several questionnaires after the medical consultation collecting sociodemographic information and their sexual well-being.
Survey using a questionnaire.
Questionnaires collecting sociodemographic information and their sexual well-being.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey using a questionnaire.
Questionnaires collecting sociodemographic information and their sexual well-being.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High-risk healthy patients undergoing risk reducing mastectomies;
* Unilateral and/or bilateral mastectomies;
* If unilateral mastectomy, both patients requiring or not contralateral mammaplasty of the healthy breast;
* All reconstructive procedures included (autologous and heterologous reconstructions).
Exclusion Criteria
* Patients who previously underwent breast cancer treatment, requiring further surgery for local relapse or secondary breast cancers;
* Delayed post-mastectomy reconstructions;
* Patients not available for e-correspondence.
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Institute of Oncology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Ospedaliero Universitaria Consorziale Policlinico
Bari, Italy, Italy
Istituto Tumori Giovanni Paolo II
Bari, Italy, Italy
Policlinico Sant'Orsola-Malpighi
Bologna, Italy, Italy
Ospedale Bufalini di Cesena
Cesena, Italy, Italy
Presidio Ospedaliero GB Morgagni-Pierantoni
Forlì, Italy, Italy
European Institute of Oncology
Milan, Italy, Italy
Ospedale Mater Olbia
Olbia, Italy, Italy
Azienda Ospedale Università di Padova
Padua, Italy, Italy
Policlinico Paolo Giaccone
Palermo, Italy, Italy
Policlinico San Matteo
Pavia, Italy, Italy
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy, Italy
Campus Biomedico
Roma, Italy, Italy
Istituto Tumori Regina Elena
Roma, Italy, Italy
Policlinico Gemelli
Roma, Italy, Italy
A.O.U. Città della salute e della scienza di Torino
Torino, Italy, Italy
Azienda Ospedaliera di Treviso
Treviso, Italy, Italy
Ospedale di Cattinara
Trieste, Italy, Italy
Ospedale Universitario di Udine
Udine, Italy, Italy
Breast Unit Settelaghi
Varese, Italy, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
L2-367
Identifier Type: OTHER
Identifier Source: secondary_id
UID 4897
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.